Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Hospital Costa Del Sol
Marbella, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Costa Del Sol (7)
2020
-
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Drug Resistance Updates, Vol. 53
2019
-
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
OncoImmunology, Vol. 8, Núm. 7
-
Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity
Cell Stress, Vol. 3, Núm. 7, pp. 236-239
-
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Nature, Vol. 569, Núm. 7756, pp. 428-432
2018
-
International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain
Cancer Immunology, Immunotherapy
2017
-
Anti-CD137 and PD-1/PD-L1 antibodies en route toward clinical synergy
Clinical Cancer Research, Vol. 23, Núm. 18, pp. 5326-5328
-
Antibody-dependent cell cytotoxicity: Immunotherapy strategies enhancing effector NK cells
Immunology and Cell Biology, Vol. 95, Núm. 4, pp. 347-355